Target intelligence / Profile preview

NADH:ubiquinone oxidoreductase subunit B4 pseudogene 4 (NDUFB4P4)

Target
NDUFB4P4
Molecular classification
Other (pseudogene)
01

Overview

NDUFB4P4 is a human pseudogene, annotated as NADH:ubiquinone oxidoreductase subunit B4 pseudogene 4. Pseudogenes arise from gene duplication or retrotransposition events but typically do not encode functional proteins. Some pseudogenes are transcribed and can regulate protein-coding genes via noncoding RNA mechanisms (such as acting as microRNA decoys, antisense transcripts, or sources of small interfering RNAs). However, there is no evidence that NDUFB4P4 itself produces functional RNA or impacts cellular processes. Like many pseudogenes, it is retained in the genome without a clear protein-coding or therapeutic role. Key context: Pseudogenes in general may have subtle regulatory roles, but most do not encode functional gene products. NDUFB4 is a subunit of mitochondrial complex I, but NDUFB4P4 is a nonfunctional copy, not involved in respiratory chain activity or disease. No interaction with drugs, no biomarker status, and no therapeutic relevance are recorded for NDUFB4P4. In summary: NDUFB4P4 is a noncoding pseudogene, not a canonical therapeutic target, and should not be listed as a drug discovery or disease-related target.

Other names
NDUFB4P4
02

Mechanism of action

None

03

Biological functions

Potential regulatory noncoding RNA roles are possible, as for some pseudogenes, but there is no evidence for a specific function for NDUFB4P4.
04

Disease associations

None known directly. Some pseudogenes are implicated in regulatory networks relevant to disease, but there is no specific disease association for NDUFB4P4.

Beyond the preview

Go deeper on NADH:ubiquinone oxidoreductase subunit B4 pseudogene 4 (NDUFB4P4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NADH:ubiquinone oxidoreductase subunit B4 pseudogene 4 (NDUFB4P4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call